Company Overview and News

China Vanke Co., Ltd. ADR 2017 Q4 - Results - Earnings Call Slides

2018-03-29 seekingalpha
The following slide deck was published by China Vanke Co., Ltd. ADR in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

Resort Operator In Tie-Up With Hard Rock For Casino Project

2018-01-17 seekingalpha
Casino industry newsletter GGRAsia reported that Hard Rock International confirmed its interest in developing a casino at the Laguna Lăng Cô beach resort development.
Upvote Downvote

Hong Kong’s Hang Seng breaks through 30,000 points, hits decade high

2017-11-22 thehindubusinessline
Hong Kong's benchmark Hang Seng Index broke through the 30,000 point-mark on Wednesday for the first time in 10 years, amid signs Chinese investors are stepping up buying Hong Kong blue chips such as Tencent. China stocks also rose.
Upvote Downvote

Hong Kong budget hotel operators show interest in moving into co-living space

2017-11-22 scmp
Hong Kong budget hotels in non-core areas are keen to join other investors to convert their underperforming properties into co-living spaces, as it provides a cheaper alternative for millennials priced out of the world’s most expensive housing market.
Upvote Downvote

Young and fashionable willing to pay a premium for co-living space as government backs segment

2017-11-22 scmp
Yuppies with the taste for communal living in Beijing are being spoiled for choice as an increasing number of private firms move into this latest strand of residential leasing, thanks to backing from the government.
Upvote Downvote

Chinese developers turn to mortgage balance-ABS for liquidity

2017-11-21 in.reuters
HONG KONG (Reuters) - Chinese developers such as China Vanke and Country Garden are increasingly turning to the securitisation market as an alternative fund-raising channel as the onshore bond market remains mostly inaccessible.
Upvote Downvote

Chinese developers turn to mortgage balance-ABS for liquidity

2017-11-21 reuters
HONG KONG (Reuters) - Chinese developers such as China Vanke (2202.HK) and Country Garden (2007.HK) are increasingly turning to the securitization market as an alternative fund-raising channel as the onshore bond market remains mostly inaccessible.
Upvote Downvote

China stocks shake off shadow bank clampdown with late rally (VIDEO)

2017-11-21 themalaymailonline
A man walks out of the Shanghai Stock Exchange building at the Pudong financial district in Shanghai November 17, 2014. — Reuters picSHANGHAI, Nov 21 — Chinese stocks rallied in late trade as markets took a closer look at the nation’s new plans to rein in shadow banks and some traders speculated that state funds would act to stem excessive losses.
Upvote Downvote

ICBC to offer 500 billion yuan worth of credit to spur home rental market in Guangzhou

2017-11-16 scmp
Industrial and Commercial Bank of China (ICBC), the nation’s largest bank by assets, said on Thursday it would offer 500 billion yuan (US$75.4 billion) worth of credit to support the home rental market in Guangzhou.
Upvote Downvote

Largest operator of warehousing space in China, Singaporean logistics giant GLP, posts 34pc second quarter profit rise

2017-11-10 scmp
Results come after finalisation of a US$11.6b management-led buyout of the firm by a consortium led by developer China Vanke Co and Goldman Sachs’ former China chairman – Asia’s biggest-ever private equity acquisition by value
Upvote Downvote

Four tap into asset-backed securities on rental flats – who’ll be next?

2017-11-08 scmp
Following Mofang and Ziroom’s successful issuance of Asset Backed Securities (ABS), China Young Professional Apartments (CYPA) and Poly Real Estate (Poly China) have now been given the green light to launch quasi-Real Estate Investment Trusts (REITs). Property developers, such as China Vanke, CIFI Holdings (Group), Longfor Properties and Landsea Green Properties, Poly China has entered the business of long-term rental spaces.
Upvote Downvote

Chinese banks being tempted into residential leasing market

2017-11-06 scmp
China Construction Bank first of country’s big four to make serious commitment, with others lining up to follow
Upvote Downvote

What's in a Chinese Sausage? - Bloomberg Gadfly

2017-11-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

With asset-backed securities sorted for builders, China now needs to develop reit market

2017-10-31 scmp
Reits are popular with investors in developed markets like the US, but legal and regulatory hurdles are preventing the launch of these products in China
Upvote Downvote

Sun Hongbin: from outside top 50 to China’s fourth-richest property tycoon in just 12 months

2017-10-30 scmp
A series of aggressive asset purchases over the past year has propelled real estate magnate Sun Hongbin into China’s top five property billionaires, from outside the top 50, 12 months ago.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...